IP Library › Granted Patent US 12,383,760
Granted Patent B2
US 12,383,760 · App. 17/685,365 · Granted Aug 12, 2025

Surgical and patient care lighting apparatus, method and controls that use multiple wavelengths and bandwidths of pathogen killing visible and ultraviolet light

Inventors: Dennis M. Anderson (Carson City, NV); Chelsea A. Doyle (Reno, NV); Lynn M. T. Anderson (Carson City, NV); Devon E. Anderson (Rochester, NY)
A61N5/0624A61N2005/0632A61N2005/0644A61N2005/0661A61N2005/0662
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,383,760
App. No.
17/685,365
Granted
Aug 12, 2025
Kind
B2
Abstract

A surgical site infection management lighting system that is effective and safe for human use to reduce or eliminate surgical site infections. The system provides multiple focused electromagnetic radiation frequencies at minimal energy levels for surgical and medical procedures that kills pathogens with electromagnetic radiation sources. The system includes an aiming laser, a distance sensor, a camera for providing images of the surgical site, and a motion sensor for providing control parameters. Fused silica lenses are utilized to focus the visible light for high illumination and selected electromagnetic radiation frequencies at minimal energy levels that are lethal to pathogens. The lighting system can be associated with an articulable arm, a mobile base stand, a handheld unit or a head-mounted unit.

Claims (31)

1. A head mountable electromagnetic radiation system for providing bactericidal, germicidal, antimicrobial and/or pathogen killing effects to a target site of a patient using electromagnetic radiation and visible light sources during a time period associated with surgical or medical procedures, the head mountable electromagnetic radiation system comprising:

a head band assembly configured to be adjustably supported on a user's head;

a first electromagnetic radiation source configured to radiate a first electromagnetic radiation at a first electromagnetic radiation frequency selected from the group consisting of 1.489-1.350 petahertz (PHz), and 999-967 terahertz (THz);

a second electromagnetic radiation source configured to radiate a second electromagnetic radiation at a second electromagnetic radiation frequency selected from the group consisting of 749-637 THz, 614-583 THz, and 475-384 THz that have pathogen destruction capabilities at engineered and administered energy dose levels;

a third light source configured to radiate visible light at a wavelength, bandwidth or frequency different than of the first electromagnetic radiation and the second electromagnetic radiation, wherein the third light source is configured for illumination of the target site; and

a control module configured or configurable to any one of or combination of receiving information from a computer system and transmitting date to the computer system, the control module being in operable communication with the first electromagnetic radiation source, the second electromagnetic radiation source and the third light source, the control module being configured or configurable to automatically control any one of or any combination of the first electromagnetic radiation source, the second electromagnetic radiation source and the third light source;

wherein the first and second electromagnetic radiation frequencies are configured or configurable to deliver human safe electromagnetic radiation at an energy level and a dose time to the target site on a patient that is effective in destroying harmful pathogens in real time as a surgery or medical procedure is in progress and thereby reducing or eliminating surgical or postoperative infections;

wherein the energy level of the first electromagnetic radiation and the second electromagnetic radiation at a predetermined power level in watts or milliwatts or microwatts multiplied by the dose time in seconds, which yields an effective electromagnetic radiation dose, which is the energy level in joules, millijoules or microjoules, and the electromagnetic radiation dose being configured or configurable for delivery to each square centimeter of the target site on the patient, and electromagnetic radiation doses are scheduled for and delivered to the target site one or multiple times during the surgery or medical procedure;

wherein the first electromagnetic radiation source is in a frequency range of 1.489-1.350 PHz are activated and configured at a power level of 800 microwatts and the dose time of 12.5 seconds that results in a dose of 10 millijoules that is delivered to the target site one or multiple times during the surgical or medical procedure to achieve human safe pathogen destruction and to not damage or kill human cells;

wherein the 1.489-1.350 petahertz electromagnetic radiation at the dose energy level of 10 millijoules is configured to destroy and kill microorganisms that are 10 to 100 times smaller than human cells, and wherein the first and second electromagnetic radiation are configured to not penetrate, affect, damage or kill the human cells because of the size of the human cells are one to two magnitudes larger than the microorganisms.

2. The head mountable electromagnetic radiation system according to claim 1 further comprising binocular lenses configured for magnification of the target site.

3. The head mountable electromagnetic radiation system according to claim 2 , wherein each of the binocular lenses is adjustably mounted to a binocular fixture that is associated with a central support mount of the head band assembly.

4. The head mountable electromagnetic radiation system according to claim 1 further comprising an indicator light configured to be visible to the user wearing the head band assembly during the surgical or medical procedure when the electromagnetic radiation dose is actively being delivered to the target site from any one of or combination of the first electromagnetic radiation source and the second electromagnetic radiation source, and wherein the computer system is configured to control the first electromagnetic radiation source and the second electromagnetic radiation source to administer several doses of electromagnetic radiation to the target site during the time period of the surgery or medical procedure, including a preoperative dose, one or multiple intraoperative doses and a postoperative dose where each dose destroys or kills 99% of microorganisms and infection causing pathogens which eliminates or reduces surgical or medical infections in postoperative patient care.

5. The head mountable electromagnetic radiation system according to claim 1 , wherein the head band assembly further comprising one or more batteries operably configured to provide power to any one of or any combination of the first electromagnetic radiation source, the second electromagnetic radiation source, the third light source and the control module.

6. The head mountable electromagnetic radiation system according to claim 1 , wherein the first electromagnetic radiation source is a plurality of first electromagnetic radiation sources with one or more of the first electromagnetic radiation sources including a focusable lens and one or more not including the focusable lens, wherein the second electromagnetic radiation source is a plurality of second electromagnetic radiation sources with one or more of the second electromagnetic radiation sources including the focusable lens and one or more of the second electromagnetic radiation sources not including the focusable lens.

7. The head mountable electromagnetic radiation system according to claim 1 further comprises a laser unit configured to radiate laser light toward an illumination area illuminated by any one of or combination of the first electromagnetic radiation source and the second electromagnetic radiation source.

8. The head mountable electromagnetic radiation system according to claim 1 further comprises a distance sensor configured to sense reflected laser light utilizable in determining a distance of and any one of or combination of the first electromagnetic radiation source and the second electromagnetic radiation source to the target site, where the distance is used to focus an area of radiation or illumination and allows for computer controlled adjustment of the head mountable electromagnetic radiation system, and is used in setting a distribution of the electromagnetic radiation frequency or frequency ranges, at the predetermined power level over a set time, which yields the effective electromagnetic radiation dose, where electromagnetic radiation frequency at a certain minimum energy level in joules, millijoules or microjoules results in the pathogen destruction, thereby achieving a reduction or elimination of site specific infections at the target site on the patient, while being safe to human cells and the patient.

9. The head mountable electromagnetic radiation system according to claim 1 further comprises a camera configured to capture an image or video of at least the target site.

10. The head mountable electromagnetic radiation system according to claim 1 further comprises a motion sensor configured to detect motion in an area above the target site or adjacent any one of or any combination of the first electromagnetic radiation source and the second electromagnetic radiation source.

11. The head mountable electromagnetic radiation system according to claim 1 further comprises a laser unit, a distance sensor, a camera and a motion sensor, wherein the computer system is configured or configurable to control any one or any combination of the first electromagnetic radiation source, the second electromagnetic radiation source and the third light source based on signals received from the distance sensor and the motion sensor.

12. The head mountable electromagnetic radiation system according to claim 1 , wherein the first electromagnetic radiation source is configured to radiate in a frequency range of 999-967 THz, where a predetermined dose of electromagnetic radiation range is a synthetic equivalent to portions of ultraviolet-B sunlight such that skin of the patient will synthesize vitamin D and D3 to promote biologic healing at the target site, where the frequency range is programmed and controlled by the computer system for safe and healing benefits, and wherein the computer system is configured to control the first electromagnetic radiation source to administer the dose to the target site during final stages of the surgery or medical procedure.

13. The head mountable electromagnetic radiation system according to claim 1 , wherein the first electromagnetic radiation source and the second electromagnetic radiation source are configured or configurable to radiate the first electromagnetic radiation and the second electromagnetic radiation, respectively, to an area larger than a largest width of the target site, where programmable controls for electromagnetic radiation beam or beams for the first and the second electromagnetic radiation sources can be set or adjusted to focus any one of or any combination of a size, a shape and dimensions, which is larger than the target site on the patient.

14. The head mountable electromagnetic radiation system according to claim 1 , wherein the first electromagnetic radiation frequency and the energy level thereof are configured to provide a radiation level sufficient to kill a set of selected pathogens and to be harmless to the patient.

15. A method of using a head mountable lighting and electromagnetic radiation system for providing bactericidal, germicidal, antimicrobial and/or pathogen killing effects to a target site of a patient or animal care, the method comprising the steps of:

a) providing an electromagnetic radiation system deployable using a head mountable device, where the electromagnetic radiation system for providing bactericidal, germicidal, antimicrobial and/or pathogen killing effects to a target site of a patient using electromagnetic radiation at an electromagnetic radiation frequency of 1.489-1.350 petahertz (PHz) and visible light sources during a time period associated with surgical or medical procedures, the electromagnetic radiation system comprising: a light source configured to radiate visible light at a wavelength, bandwidth or frequency for illumination which provides the surgeon and medical staff optimal vision while performing a surgical or medical procedure;

where the head mountable device is a lighting and electromagnetic radiation system that is worn by a physician or medical staff where a distance to the target site is dependent on surgeon lighting preferences, and where the distance will be adjusted as the surgeon or medical staff moves several times during the surgical or medical procedure, where a laser mounted in the center of the head mountable device is transmitting on a middle of the target site and the laser will simultaneously measure the distance to the target site, where the distance is used to calculate and subsequently make automated adjustments to power of the electromagnetic radiation to deliver a human safe pathogen destroying dose of the electromagnetic radiation, and the electromagnetic radiation system is programmed to make changes in the power in microwatts or milliwatts based on the distance so that the same electromagnetic radiation dose in microjoules or millijoules is delivered during each scheduled pathogen destruction electromagnetic radiation when the distance varies, and where every distance between the lighting and electromagnetic radiation system and the target site receives the same electromagnetic radiation dose during the delivered one or multiple times during surgical or medical procedure duration for the pathogen destruction doses to the target site in real time;

wherein system engineering and computer programming makes automatic adjustments in the lighting and electromagnetic radiation system that results in killing and destroying pathogens while the doses of electromagnetic radiation are harmless to patients and medical providers.

16. The method according to claim 15 , wherein the electromagnetic radiation is engineered and programed to deliver human safe doses of 1.489-1.350 PHz electromagnetic radiation on a scheduled basis during the time of the surgical or medical procedure to deliver multiple human safe pathogen killing radiation over the entire medical procedure uses doses that include pre-operation dosing, interoperative dosing and post-operation dosing where the total surgical or medical procedure dose is at the 1.489-1.350 PHz electromagnetic radiation, and a total number of individual doses be accounted for and will provide human exposure, and a computer system is configured or configurable to deliver the electromagnetic radiation at a constant power where each effective dose at the target site will vary with the distance between the lighting and electromagnetic radiation system where a highest dose will occur at a shortest distance between the lighting and electromagnetic radiation system and the target site, a lowest dose will occur at a greatest distance between the lighting and electromagnetic radiation and the target site; and

wherein the head mountable lighting and electromagnetic radiation system is configured or configurable to not make automatic dose adjustments to account for an elevation adjustment of the lighting and electromagnetic radiation system and the target site, and where all multiple dose of the 1.489-1.350 PHz electromagnetic radiation during the surgical or medical procedure is designed and delivered to be human safe, where the constant power in microwatts or milliwatts will result in a dose energy at the target site in a dose of microjoules or millijoules for killing and destroying pathogens at the target site when a height of the head mountable lighting and electromagnetic radiation system adjusted.

17. The method according to claim 15 , wherein the electromagnetic radiation frequency of 1.489-1.350 PHz frequency and the energy level thereof are configured to provide a radiation level in microjoules or millijoules that is sufficient to kill a set of selected pathogens and to be harmless to the patient where a total daily dose is human safe.

18. The method according to claim 15 , further comprises a computer system that is configured or configurable to control the electromagnetic radiation frequency of 1.489-1.350 PHz sources to administer several doses of electromagnetic radiation to the target site during the time period of the surgery or medical procedure, including a preoperative dose, one or multiple intraoperative doses and a postoperative dose where each dose is configured to destroy or kill 99% of microorganisms and infection causing pathogens which eliminates or reduces surgical or medical infections in postoperative patient care.

Continuity (4)
Continuation 17062811 · Oct 5, 2020
Provisional Application 63003875 · Apr 1, 2020
Provisional Application 62987692 · Mar 10, 2020
Related Publication 20220184415A1 · Jun 16, 2022
References Cited (93)
US 2215634A · Collins et al. · 1940 [cited by applicant]
US 5047072A · Wertz et al. · 1991 [cited by applicant]
US 5072346A · Harding · 1991 [cited by applicant]
US 5093769A · Luntsford · 1992 [cited by applicant]
US 5871522A · Sentilles · 1999 [cited by applicant]
US 6156503A · Drazen et al. · 2000 [cited by applicant]
US 6461354B1 · Olsen et al. · 2002 [cited by applicant]
US 6528306B1 · Snyder et al. · 2003 [cited by applicant]
US 6541255B1 · Snyder et al. · 2003 [cited by applicant]
US 6573491B1 · Marchitto et al. · 2003 [cited by applicant]
US 6680198B1 · Snyder et al. · 2004 [cited by applicant]
US 6724958B1 · German et al. · 2004 [cited by applicant]
US 6890346B2 · Ganz et al. · 2005 [cited by applicant]
US 7114405B2 · S?nwoldt et al. · 2006 [cited by applicant]
US 7677296B2 · Mason · 2010 [cited by applicant]
US 7776824B2 · Barasch et al. · 2010 [cited by applicant]
US 7977110B2 · Barasch et al. · 2011 [cited by applicant]
US 8027554B2 · Takahashi · 2011 [cited by applicant]
US 8247376B2 · Barasch et al. · 2012 [cited by applicant]
US 8481077B2 · Kheir et al. · 2013 [cited by applicant]
US 8531818B2 · Hashimoto et al. · 2013 [cited by applicant]
US 8817085B2 · Hiltl et al. · 2014 [cited by applicant]
US 9081878B2 · Rofougaran · 2015 [cited by applicant]
US 9162078B2 · Irwin · 2015 [cited by applicant]
US 9220536B2 · Skaggs · 2015 [cited by applicant]
US 9278232B2 · Gerstenmeier · 2016 [cited by applicant]
US 9517280B2 · Lynn et al. · 2016 [cited by applicant]
US 9662409B2 · Rains, Jr. et al. · 2017 [cited by applicant]
US 9814906B2 · McDaniel · 2017 [cited by applicant]
US 10010709B2 · Kohane et al. · 2018 [cited by applicant]
US 10046175B2 · Gerber · 2018 [cited by applicant]
US 10064940B2 · Nager · 2018 [cited by applicant]
US 10483206B2 · Khalid · 2019 [cited by applicant]
US 11298564B2 · Anderson · 2022 [cited by examiner]
US 20060167531A1 · Gertner · 2006 [cited by examiner]
US 20070045197A1 · Ogut et al. · 2007 [cited by applicant]
US 20070255266A1 · Cumbie · 2007 [cited by examiner]
US 20080183081A1 · Lys · 2008 [cited by examiner]
US 20090143842A1 · Cumbie · 2009 [cited by examiner]
US 20100234794A1 · Weadock et al. · 2010 [cited by applicant]
US 20110015492A1 · Mangiardi · 2011 [cited by applicant]
US 20110054574A1 · Felix · 2011 [cited by applicant]
US 20110202116A1 · Barolet et al. · 2011 [cited by applicant]
US 20120206050A1 · Spero · 2012 [cited by applicant]
US 20130274839A1 · Johnson et al. · 2013 [cited by applicant]
US 20160016001A1 · Loupis et al. · 2016 [cited by applicant]
US 20160082281A1 · Gerber · 2016 [cited by applicant]
US 20170239489A1 · Bourke, Jr. et al. · 2017 [cited by applicant]
US 20180214585A1 · Piper · 2018 [cited by examiner]
US 20190046812A1 · Harlan et al. · 2019 [cited by applicant]
US 20190249847A1 · Hallack et al. · 2019 [cited by applicant]
US 20190255201A1 · Rosen et al. · 2019 [cited by applicant]
US 20190262629A1 · Broer · 2019 [cited by examiner]
US 20190282718A1 · Cole · 2019 [cited by applicant]
US 20200205268A1 · Pereyra et al. · 2020 [cited by applicant]
US 20220016437A1 · Jarausch · 2022 [cited by examiner]
US 20220184414A1 · Anderson et al. · 2022 [cited by applicant]
US 20220184415A1 · Anderson et al. · 2022 [cited by applicant]
WO 2008076986A1 · 2008 [cited by applicant]
WO 2011002209A2 · 2011 [cited by applicant]
WO 2012122210A1 · 2012 [cited by applicant]
WO PCTUS2021019392A1 · 2021 [cited by applicant]
S. Adibi (ed.), Mobile Health, Springer International Publishing Switzerland 2015. [cited by applicant]
M. Buonanno, 207-nm UV—A Promising Tool for Safe Low-Cost Reduction of Surgical Site Infections. I: In Vitro Studies, Center for Radiological Research, Columbia University, NY, NY, Oct. 2013. [cited by applicant]
R. Lubart, A Possible Mechanism for the Bactericidal Effect of Visible Light, Department of Chemistry and Physics, Bar-Ilan University, Israel. Nov. 2010. [cited by applicant]
D. Welch, Far-UVC Light: A new tool to control the spread of airborne-mediated microbial diseases, Scientific Report 8, Article No. 2752, Feb. 2018. [cited by applicant]
K. Crysel, Exposure to Ultraviolet Radiation in the Operating Room, Official Journal of the Anesthesia Patient Safety Foundation, 2010. [cited by applicant]
N. Dabai, The Effect of Ultraviolet Radiation from Novel Portable Fluorescent Lamp on Serum 25-Hydroxyyitamin D3 Levels in Healthy Adults with Fitzpatrick Skin Type I and II, www.nlm.gov/pmc/articls/PMC3491578. [cited by applicant]
H. Takiwaki, Measurement of Skin Color: practice applications and theorical considerations, Journal of Medical Investigation, University of Tokushima, School of Medicine, Tokushima, Japan. [cited by applicant]
American Air and Water, UV Irradiation Dosage Table, www.americanairandwater.com/uvfacts/uv-dosage.htm. [cited by applicant]
David Niven Miller, Ridge, Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. Jan. 3, 2019. N England J Med 2019; 380:33-44, DOI: 10.1056/NEJMoa1809944. [cited by applicant]
P. H. Hart, Modulation of the immune system by UV radiation: more than just the effects of vitamin D?, Macmillan Publishers Limited. Sep. 2011. [cited by applicant]
J.C. Ball, A comparison of the UV-B irradiance of low-intensity, full spectrum lamps with natural sunlight, Melissa Kaplan' Herp Care Collection, Jan. 2014. [cited by applicant]
Welsh, David, Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases, Scientific Reports, vol. 8, Article No. 2752, 2018. [cited by applicant]
Buonanno, M., Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light, DOI: 10.1667/rr0010cc. 1, Feb. 2017. [cited by applicant]
Nozomi Yamano et al. Long-term effects of 222 nm ultraviolet radiation C sterilizing lamps on mice susceptible to ultraviolet radiation, Photochemistry and Photobiology, Mar. 2020, DOI: 10.1111/php.13269. [cited by applicant]
Chandrasekaran, Baskaran, et al. “Short-term multi modal phototherapy approach in a diabetic ulcer patient.” Singapore Med J 53.6 (2012): 122-4. (Year: 2012). [cited by applicant]
Sunsmart, Vitamin D and UV radiation, Feb. 2016. [cited by applicant]
Buonanno et al., (2013) 207-nm UV Light—A Promising Tool for Safe Low-Cost Reduction of Surgical Site Infections. I: In Vitro Studies. PLoS One 8(10): e76968. doi:10.1371/journal.pone.0076968. [cited by applicant]
Bumah et al., Wavelength and Bacterial Density Influence the Bactericidal Effect of Blue Light on Resistant [cited by applicant]
Kobe University, Repetitive irradiation with 222nm UVC non-carcinogenic, safe fro sterilizing human skin, Apr. 7, 2020. [cited by applicant]
Buonanno et al., Far-UVC light (222 nm) eiciently and safely inactivates airborne human coronaviruses, Scientific RepoRtS, (2020) 10:10285, https://doi.org/10.1038/s41598-020-67211-2. [cited by applicant]
Buonanno et al., Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light, Apr. 2017. [cited by applicant]
Childress et al., Disinfection with Far-UV (222 nm Ultraviolet light) , Boeing, National Academies of Sciences, Engineering, and Medicine: Washington, DC. Held Sep. 16, 2020., https://www.nationalacademies.org/event/09-… [cited by applicant]
Far UV Technologies, ACGIH increases Threshold Limit Values—Far UV | 222nm Far UV-C Excimer Lamp Disinfection Lighting, 2021. [cited by applicant]
Eadia et al., Extreme Exposure to Filtered Far-UVC: A Case Study, Photochem Photobiol, May-Jun. 2021, 97(3): 527-531, Published online Feb. 3, 2021. doi: 10.1111/php.13385. [cited by applicant]
Blatchley III et al., Far UV-C Radiation: Current State-of Knowledge, UVA webinar presented in May 2021. [cited by applicant]
Jamie Childress, Using 222-nm Ultraviolet (UV) Light for Safer Disinfection, Military Health System, https://health.mil/-/media/Images/MHS/Photos/fluorescent-brain.ashx, Mar. 22, 2021. [cited by applicant]
Woods et al., The effect of 222-nm UVC phototesting on healthy volunteer skin: a pilot study, Photodermatol Photoimmunol Photomed 2015; 31: 159-166. [cited by applicant]
Sliney et al., A Need to Revise Human Exposure Limits for Ultraviolet UV-C Radiation, Photochemistry and Photobiology, vol. 97, Issue 3, p. 485-492, Feb. 16, 2021. [cited by applicant]
Cabral et al., Blue Light Disinfection in Hospital Infection Control: Advantages, Drawbacks, and Pitfalls, Antibiotics (Basel). Jun. 2019; 8(2): 58. Published online May 7, 2019, doi: 10.3390/antibiotics8020058. [cited by applicant]
Patient Carlink, Glossary of Healthcare Terms. [cited by applicant]
Gwynne et al., Light as a Broad-Spectrum Antimicrobial, Front Microbiol, 2018; 9: 119, Published online Feb. 2, 2018. doi: 10.3389/fmicb.2018.00119. [cited by applicant]